title: [Pneumonia due to Yersinia enterocolitica].
authors.forename: P-A
authors.initials: PA
authors.lastname: Jarrot
authors.forename: R
authors.initials: R
authors.lastname: Mahmoudi
authors.forename: J-L
authors.initials: JL
authors.lastname: Novella
authors.forename: P
authors.initials: P
authors.lastname: Manckoundia
mesh_terms: D000230:Adenocarcinoma / Q000150:complications; D000368:Aged; D000437:Alcoholism / Q000150:complications; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D002439:Cefotaxime / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications; D004198:Disease Susceptibility; D016889:Endometrial Neoplasms / Q000150:complications; D005260:Female; D006801:Humans; D019190:Iron Overload / Q000150:complications; D018410:Pneumonia, Bacterial / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D015009:Yersinia Infections / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D015008:Yersinia enterocolitica / Q000302:isolation & purification*
chemical_list: D000900:Anti-Bacterial Agents; D002439:Cefotaxime